Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 1 Published - 14:00 UTC    08:00 EST    23-September-2000      
Issue 163 Next Update - 14:00 UTC 08:00 EST    24-September-2000      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Proceed To Article In Today's Vidyya
Reports
NIDA releases a toolbox to help professionals deal with the problems of drug abuse.


Proceed To Article NIDA Clinical Toolbox Provides The Latest Information About Drug Treatment Strategies
Nearly 12,000 drug treatment programs around the country will benefit from years of drug abuse and addiction research thanks to the NIDA Clinical Toolbox: Science-Based Materials for Drug Abuse Counselors. The toolbox, packaged in a bright gray box with a large "TX" on the front, will be available later this month from the National Institute on Drug Abuse (NIDA). More...

Proceed To Article Whooping Cough Vaccination Needed For Teens And Adults
Medical researchers meeting in Toronto this week called for a vaccination program to combat the increasing incidence of pertussis (whooping cough) among adolescents and adults. More...

Proceed To Article Pertusis - Information For Health Professionals
In unimmunized populations in the world, pertussis remains a major health problem among children, with an estimated 300,000 deaths per year due to the disease. This chapter is an in-depth look at the disease and its prevention. More...

Proceed To Article Canadian Association Of Radiologists Has Strong Criticism For NCI Breast Screening Study
The Canadian National Breast Screening Study-2 (CNBSS-2) published Thursday in the Journal of the National Cancer Institute may be flawed because it is based on poor quality mammograms that were done before the introduction of specific training and quality accreditation in mammography and because of the basic design of the study. The CNBSS-2 falsely concludes that adding mammography for breast cancer screening to physical examinations does not reduce deaths. More...

Proceed To Article

FDA Deadline For RU-486 Quickly Approaching
The Food and Drug Administration (FDA) is set to decide the fate of mifepristone -- formerly known as RU-486, the French abortion pill -- by 30 September 2000. More...


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.